These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 12420343

  • 21. [Neopterin--a prognostic marker in HIV infection].
    Breustedt W, Rabe H, Volk D, Porstmann P.
    Dermatol Monatsschr; 1989; 175(4):226-31. PubMed ID: 2499491
    [Abstract] [Full Text] [Related]

  • 22. [Adenosine deaminase (ADA) and beta 2-microglobulin (beta 2M) as discriminating serum markers of progression to AIDS].
    Pérez de Oteyza C, Menéndez Martínez MA, Irazábal C, Enríquez de Salamanca R, Pérez Aznar C, Rebollar JL.
    An Med Interna; 1996 May; 13(5):217-21. PubMed ID: 8767867
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia.
    Royal W, Selnes OA, Concha M, Nance-Sproson TE, McArthur JC.
    Ann Neurol; 1994 Jul; 36(1):32-9. PubMed ID: 7912918
    [Abstract] [Full Text] [Related]

  • 29. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
    Whittle H, Egboga A, Todd J, Corrah T, Wilkins A, Demba E, Morgan G, Rolfe M, Berry N, Tedder R.
    AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
    [Abstract] [Full Text] [Related]

  • 30. Serum beta 2-microglobulin and human immunodeficiency virus infection.
    Lacey JN, Forbes MA, Waugh MA, Cooper EH, Hambling MH.
    AIDS; 1987 Jul; 1(2):123-7. PubMed ID: 3130078
    [Abstract] [Full Text] [Related]

  • 31. [Estimated biological markers of progression in human immunodeficiency virus infection].
    Bélec L, Ripoll L, Matta F, Mbopi Kéou FX, Cotigny S, Longuet MF, Jacob A.
    Ann Biol Clin (Paris); 1992 Jul; 50(9):621-37. PubMed ID: 1298168
    [Abstract] [Full Text] [Related]

  • 32. Immunological markers of disease progression in patients infected with the human immunodeficiency virus.
    Pascale JM, Isaacs MD, Contreras P, Gomez B, Lozano L, Austin E, De Martin MC, Gregory RL, McLaughlin GL, Amador A.
    Clin Diagn Lab Immunol; 1997 Jul; 4(4):474-7. PubMed ID: 9220167
    [Abstract] [Full Text] [Related]

  • 33. Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection.
    Look MP, Rockstroh JK, Rao GS, Kreuzer KA, Spengler U, Sauerbruch T.
    Biol Trace Elem Res; 1997 Jan; 56(1):31-41. PubMed ID: 9152510
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. HLA class I soluble antigen serum levels in HIV-positive subjects--correlation with cellular and serological parameters.
    Puppo F, Orlandini A, Ruzzenenti R, Comuzio S, Salamito A, Farinelli A, Stagnaro R, Indiveri F.
    Cancer Detect Prev; 1990 Jan; 14(3):321-3. PubMed ID: 2117484
    [Abstract] [Full Text] [Related]

  • 40. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Dis Markers; 1990 Jan; 8(3):164-5. PubMed ID: 2125538
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.